Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PLUS THERAPEUTICS, INC. | Chief Financial Officer | Common Stock | 9.82K | $12.5K | $1.27 | Sep 10, 2024 | Direct |
PLUS THERAPEUTICS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 46.1K | Sep 11, 2024 | Direct | ||
PLUS THERAPEUTICS, INC. | Chief Financial Officer | Warrants (Right to buy) | 9.8K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PSTV | PLUS THERAPEUTICS, INC. | Sep 11, 2024 | 1 | $0 | 4 | Sep 12, 2024 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Sep 10, 2024 | 1 | $5.2K | 4 | Sep 11, 2024 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | May 8, 2024 | 2 | $10K | 4 | May 10, 2024 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Apr 26, 2022 | 1 | $2.02K | 4 | Apr 27, 2022 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Mar 1, 2022 | 1 | $2.2K | 4 | Mar 3, 2022 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Nov 2, 2021 | 1 | $1.86K | 4 | Nov 4, 2021 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Oct 26, 2021 | 1 | $3.34K | 4 | Oct 27, 2021 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | Jul 27, 2021 | 2 | $8.36K | 4 | Jul 29, 2021 | Chief Financial Officer |
PSTV | PLUS THERAPEUTICS, INC. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Chief Financial Officer |